BSX 5 ½ 06/01/23 Pfd

Boston Scientific Corp

Credit, Healthcare


Publicly traded companies mentioned herein: Boston Scientific Corp (BSX)

Highlights

The presenter is long Boston Scientific’s preferred stock with a mandatory conversion at its maturity date in June 2023. This preferred issue carries a 5.5% coupon, currently trades around 108, and is convertible to 2.4 common shares. He finds these convertible units to be an attractive way to take advantage of potential appreciation in the stock while generating a current yield of ~5%.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.